A Survey of Genome Editing Activity for 16 Cas12a Orthologs
© 2019 by The Keio Journal of Medicine. The class 2 CRISPR-Cas endonuclease Cas12a (previously known as Cpf1) offers several advantages over Cas9, including the ability to process its own array and the requirement for just a single RNA guide. These attributes make Cas12a promising for many genome en...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Keio Journal of Medicine
2021
|
| Online Access: | https://hdl.handle.net/1721.1/138386 |